Deutsche Bank’s Seaport Therapeutics SPTX Stock Holding History

Deutsche Bank’s Portfolio SPTX Stock Details SPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$243K	Buy	+12,024	New	+$267K	﹤0.01%	2993

Other funds holding SPTX

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Deutsche Bank's SPTX Position: Q3 2026 in Review

Deutsche Bank opened a new position in Seaport Therapeutics (SPTX) in Q3 2026: 12,024 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #2993 among its holdings.

13 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

Deutsche Bank held 12,024 shares of Seaport Therapeutics worth $243K as of Q3 2026.
Seaport Therapeutics was a new Deutsche Bank position in Q3 2026.
Seaport Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2993 holding.
13 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.